DSM Inks Pact with Indoco for APIs
Jan 31, 2012
By joe , prnewswire.com
Tag: APIs,Dsm, Indoco
In line with DSM and Indoco's strategy, the agreement represents a step to forge an alliance to expand presence in markets across the globe.
Royal DSM N.V. announced Tuesday that the company has signed an agreement with India-based Indoco Remedies Limited for commercial cooperation for eight Active Pharmaceutical Ingredients (APIs). Founded in 1947, Indoco Remedies is one of the leading manufacturers of APIs and Finished Dosages in India for various therapeutic classes.
The alliance came into effect in January 2012. In line with DSM and Indoco's strategy, the agreement represents a step to forge an alliance to expand presence in markets across the globe.
The API's manufactured by Indoco and to be marketed and sold by DSM are used in the production of pharmaceutical Finished Dosages. This alliance will leverage Indoco's product development and cGMP compliant manufacturing capabilities and DSM's market access.
In addition DSM will use its operation and quality systems to allow faster growth in regulated markets.
Alexander Wessels, President and Chief Executive Officer, DSM Pharmaceutical Products (DPP) stated, "This is a step in our announced strategy to accelerate growth via partnerships and expansion in Asia to build a product portfolio along side our custom manufacturing operations, supplying access to high demand treatments. It allows DPP to build a competence base in India."
If you believe an article violates your rights or the rights of others, please contact us.
